KDL(SH:603987) Xin Lang Cai Jing·2025-09-01 05:22Group 1 - The core viewpoint of the news is that Kangdelai's stock price increased by 5.06% to 9.55 CNY per share, with a trading volume of 193 million CNY and a turnover rate of 4.76%, resulting in a total market capitalization of 4.171 billion CNY [1] - Kangdelai, established on July 1, 1998, and listed on November 21, 2016, is primarily engaged in the research, production, sales, and service of medical devices, including puncture needles, infusion devices, and interventional instruments [1] - The revenue composition of Kangdelai's main business includes: puncture care at 63.43%, specimen collection at 13.96%, other categories at 13.23%, medical beauty at 5.30%, and puncture intervention at 4.08% [1] Group 2 - From the perspective of Kangdelai's top ten circulating shareholders, the Guoshou Anbao Fund holds a significant position, with the Guoshou Anbao Smart Life Stock A (001672) maintaining 4.21 million shares, unchanged from the previous period, representing 0.96% of circulating shares [2] - The Guoshou Anbao Smart Life Stock A (001672) has a current scale of 1.828 billion CNY and has achieved a year-to-date return of 38.43%, ranking 687 out of 4223 in its category, with a one-year return of 86.88%, ranking 608 out of 3780 [2] Group 3 - The fund manager of Guoshou Anbao Smart Life Stock A (001672) is Zhang Qi, who has a cumulative tenure of 15 years and 60 days, with the fund's total asset size at 2.317 billion CNY [3] - During Zhang Qi's tenure, the best fund return was 164.66%, while the worst return was -19.09% [3]